Search

This week is a reminder that markets don’t always go up. The big surprise was that it took so long for global markets to wake up to the threat.

This week a number of Explorer stock retraced last week’s gains, with a major exception being the explosive 45% surge in Virgin Galactic (SPCE) on top of its previous week’s 25% surge. It appears that key test flights are forthcoming as well as more space mania and space ETFs.

Why are markets continuing to move upward in the midst of economic and political upheaval? The short answer is don’t fight the Fed, which has made it abundantly clear that it will do anything necessary to keep this economy and market moving.

This note includes our review of earnings from Mattel (MAT) and Nokia (NOK). Next week starts the deluge, with Vodafone (VOD), Dril-Quip (DRQ), General Electric (GE), Xerox (XRX), Polaris Industries (PII), Holcim (HCMLY), Kraft Heinz (KHC), M/I Homes (MHO), Lamb Weston (LW), Janus Henderson Group (JHG), Shell (SHEL) and Newell Brands (NWL) reporting.

There were no ratings or price target changes this week.

The market isn’t spiraling downwards anymore. It’s actually looking healthy again. The next stages of this market should be ideal for dividend payers and the relative return of dividend stocks in the upcoming quarters and years could be the best in a long time. Only one rating change today as we are selling a half position.

Bargain stocks are harder to come by these days with the market near all-time highs. Here are six undervalued companies that are primed for big growth.

When I recommended TSLA stock back in December 2011, the only Tesla cars on the street were the two-seat Roadsters.

Back on Monday, I tackled the big challenge of our healthcare system once again, beginning with a few personal stories--including the $840 bill for my wife’s sliced thumb--and finishing with a prediction that the big pharmaceutical companies were in for tough sledding once Washington begins a serious effort to reduce costs. The responses to the column were numerous and excellent, and I share the best with you here.

Cannabis stocks and exchange-traded funds (ETFs) are ending the year at their lowest levels ever, and everyone knows exactly why. Sector investors were let down by lawmakers in Washington, D.C. who had suggested they’d secure approval of favorable banking reform by year-end while they still had the votes. This reform would have been a game changer since it would provide cannabis companies access to banking services and maybe even listings on major exchanges.

Today’s new addition is, like last month’s, a stock that has bucked the broad market’s trend and gone up!
It’s an industrial biotechnology stock. And the secret to its success lies in a proprietary technology platform that uses artificial intelligence and machine learning to create new proteins for use in various industries.

There’s not much to like about stocks right now. But rising earnings estimates is a rare trait that can identify the next turnaround story.

Want to construct the “perfect stock”? Here are the 13 attributes to look for, according to legendary investor Peter Lynch.

International stocks have lagged U.S. markets for the last decade. But with the valuation gap wider than ever, that appears to be changing.

How many stocks should you own? Not too little. Not too much. Here’s how to find the sweet spot for your investment portfolio.

The stock market successfully weathered a global pandemic and the accompanying recession. Could rising inflation be what ends the rally?

A decade ago, following the subprime mortgage crisis, housing stocks became attractive bargains. And that’s where energy stocks are today.

Interest rates remain low and stock prices remain elevated. Where can an income investor turn? Try these two monthly-paying REITs.

Bargain stocks are hard to come by in today’s market. One useful tool in finding them is the EV/sales ratio. Here’s what to look for.

While the rest of the market retreats, these three resilient stocks have been trending up. Here’s why they might just be getting started.

As has become painfully obvious in recent weeks, inflation investing is a big challenge. But history says the pain won’t last long.